Single-centre experience with tunnelled central venous catheters in 150 cancer patients

Netherlands Journal of Medicine

Volumn 60, Issue 10, 2002, Pages 397-401

  Koolen, D A ^a   van Laarhoven, H W M ^a   Wobbes, Th ^a   Punt, C J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; FLUOROURACIL; INTERLEUKIN 2; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CULTURE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE REMOVAL; DRUG MEGADOSE; ECHOGRAPHY; EXPERIENCE; FEMALE; FREQUENCY ANALYSIS; GRANULOCYTOPENIA; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MELANOMA; PHLEBOGRAPHY; PNEUMOTHORAX; RESIDENT; RETROSPECTIVE STUDY; SKILL; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY; THROMBOSIS; VASCULAR ACCESS; EVALUATION; FOREIGN BODY; INFECTION; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; NEOPLASM; NETHERLANDS; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERIZATION, CENTRAL VENOUS; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; NETHERLANDS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOSIS; TREATMENT OUTCOME;

EID: 0036878738     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973;136:602-6.
2. Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871-5.
3. Ray S, Stacey R, Imrie M, Filshie J. A review of 560 Hickman catheter insertions. Anaesthesia 1996;51:981-5.
4. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995;13:233-8.
5. Lemmers NW, Gels ME, Sleijfer DT et al. Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol 1996;14:2916-22.
6. Freytes CO, Reid P, Smith KL. Long-term experience with a totally implanted catheter system in cancer patients. J Surg Oncol 1990;45:99-102.
7. Lokich JJ, Bothe A Jr, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol 1985;3:710-7.
8. Hartkamp A, Boxtel AJ van, Zonnenberg BA, Witteveen PO. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 2000;57:215-23.
9. Puel V, Caudry M, Metayer P le, et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 1993;72:2248-52.
10. Punt CJ, Strijk S van der, Hoeven JJ van de, Verhagen CA. Spontaneous fracture of implanted central venous catheters in cancer patients: report of two cases and retrospective analysis of the 'pinch-off-sign' as a risk factor. Anticancer Drugs 1995;6:594-8.
11. Eastman ME, Khorsand M, Maki DG, et al. Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Cancer 2001;91:806-14.
12. Klempner MS, Noring R, Mier JW, Atkins MB. An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med 1990;322:959-65.
13. Jablons D, Bolton E, Mertins S, et al. IL-2-based immunotheraphy alters circulating neutrophil Fc receptor expansion and chemotaxis. J Immunol 1990;144:3630-6.
14. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 1992;267:2072-6.
15. Darouiche RO. Prevention of vascular catheter-related infections. Neth J Med 1999;55:92-9.
16. Lim SH, Smith MP, Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. Eur J Haematol Suppl 1993;54:10-3.
17. Carratala J. The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin Microbiol Infect 2002;8:282-9.
18. Haslett TM, Isenberg HD, Hilton E, Tucci V, Kay BG, Vellozzi EM. Microbiology of indwelling central intravascular catheters. J Clin Microbiol 1988;26:696-701.
19. Bock SN, Lee RE, Fisher B, et al. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol 1990;8:161-9.
20. Eskens FALM, Punt C, Verhagen C. Thrombo-embolische complicaties van centraal-veneuze katheters. Ned Tijdschr Geneeskd 1996;140:2302.
21. Nightingale CE, Norman A, Cunningham D, Young J, Webb A, Filshie J. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur J Cancer 1997;33:398-403.
22. Gemlo BT, Rayner AA, Swanson RJ, Young JA, Hormann JF, Hohn DC. Extravasation. A serious complication of the split-sheath introducer technique for venous access. Arch Surg 1988;123:490-2.
23. Klaveren RJ van, Mulder PHMD, wobbes TH, Speth PAJ. De centraal-veneuze catheter bij de behandeling van patiëten met een maligniteit. Ned Tijdschr Geneeskd 1989;133:1629-33.